Macro Finance
Moderna, Merck Cancer Vax Gives Hope
Bloomberg Markets·August 21, 2026·1 min read
An mRNA cancer vaccine developed by Merck & Co. and Moderna Inc. kept melanoma from returning in a large, late-stage trial, marking a critical next chapter for the technology. The news fulfills a decades-long quest to use vaccines to teach the immune system to spot and destroy cancer cells, despite post-pandemic political backlash and years of false starts.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.